Isotopic Biomarkers for Rapid Assessment of Bone Mineral Balance in Biomedical Applications

Ariel Anbar (Inventor)

Research output: Patent

Abstract

Loss of bone mineral content leads to a variety of significant medical problems including osteoporosis. Development of new treatments for metabolic bone disease as well as evaluation of the efficacy of current treatments is severely hampered by the lack of a reliable tool for quickly measuring changes in bone mineral balance (BMB). Methods to sensitively measure BMB could tremendously benefit research and clinical practice in the study and treatment of bone disease. Researchers at Arizona State University have developed a novel technique that utilizes tracer-less calcium isotopes to measure net bone mineral balance. This technique analyzes changes in the natural isotope composition of calcium in blood and urine resulting from the balance of bone formation vs. resorption. Utilizing mass spectrometry, changes in bone mineral balance may be revealed with unprecedented speed and detail. Measurement of a complimentary strontium isotope biomarker provides, with equal rapidity, information on the speed of exchange of calcium between soft tissue and mineralized compartments. Ca isotope analysis provides a powerful means to monitor bone loss and therapeutic efficacy of treatments. Moreover, it may allow for new and quicker diagnoses of metabolic bone diseases in a safe and rapid manner. Potential Applications Bone mineral balance research Early detection of bone disease Assessment of effectiveness of current treatments Accelerate the pace of discovery of new treatments for metabolic bone disease Benefits and Advantages Early detection - long before bone damage occurs Rapid results High level of detail Safe only uses blood or urine Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Anbar's departmental webpage Dr. Anbar's research webpage
Original languageEnglish (US)
StatePublished - Jan 29 2010

Fingerprint

Minerals
Biomarkers
Bone and Bones
Calcium Isotopes
Metabolic Bone Diseases
Bone Diseases
Research
Strontium Isotopes
Inventors
Urine
Therapeutics
Osteogenesis
Isotopes
Bone Density
Osteoporosis
Early Diagnosis
Mass Spectrometry
Research Personnel
Calcium

Cite this

@misc{2249eb77e3284703b9990669ccc35cb7,
title = "Isotopic Biomarkers for Rapid Assessment of Bone Mineral Balance in Biomedical Applications",
abstract = "Loss of bone mineral content leads to a variety of significant medical problems including osteoporosis. Development of new treatments for metabolic bone disease as well as evaluation of the efficacy of current treatments is severely hampered by the lack of a reliable tool for quickly measuring changes in bone mineral balance (BMB). Methods to sensitively measure BMB could tremendously benefit research and clinical practice in the study and treatment of bone disease. Researchers at Arizona State University have developed a novel technique that utilizes tracer-less calcium isotopes to measure net bone mineral balance. This technique analyzes changes in the natural isotope composition of calcium in blood and urine resulting from the balance of bone formation vs. resorption. Utilizing mass spectrometry, changes in bone mineral balance may be revealed with unprecedented speed and detail. Measurement of a complimentary strontium isotope biomarker provides, with equal rapidity, information on the speed of exchange of calcium between soft tissue and mineralized compartments. Ca isotope analysis provides a powerful means to monitor bone loss and therapeutic efficacy of treatments. Moreover, it may allow for new and quicker diagnoses of metabolic bone diseases in a safe and rapid manner. Potential Applications Bone mineral balance research Early detection of bone disease Assessment of effectiveness of current treatments Accelerate the pace of discovery of new treatments for metabolic bone disease Benefits and Advantages Early detection - long before bone damage occurs Rapid results High level of detail Safe only uses blood or urine Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Anbar's departmental webpage Dr. Anbar's research webpage",
author = "Ariel Anbar",
year = "2010",
month = "1",
day = "29",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Isotopic Biomarkers for Rapid Assessment of Bone Mineral Balance in Biomedical Applications

AU - Anbar, Ariel

PY - 2010/1/29

Y1 - 2010/1/29

N2 - Loss of bone mineral content leads to a variety of significant medical problems including osteoporosis. Development of new treatments for metabolic bone disease as well as evaluation of the efficacy of current treatments is severely hampered by the lack of a reliable tool for quickly measuring changes in bone mineral balance (BMB). Methods to sensitively measure BMB could tremendously benefit research and clinical practice in the study and treatment of bone disease. Researchers at Arizona State University have developed a novel technique that utilizes tracer-less calcium isotopes to measure net bone mineral balance. This technique analyzes changes in the natural isotope composition of calcium in blood and urine resulting from the balance of bone formation vs. resorption. Utilizing mass spectrometry, changes in bone mineral balance may be revealed with unprecedented speed and detail. Measurement of a complimentary strontium isotope biomarker provides, with equal rapidity, information on the speed of exchange of calcium between soft tissue and mineralized compartments. Ca isotope analysis provides a powerful means to monitor bone loss and therapeutic efficacy of treatments. Moreover, it may allow for new and quicker diagnoses of metabolic bone diseases in a safe and rapid manner. Potential Applications Bone mineral balance research Early detection of bone disease Assessment of effectiveness of current treatments Accelerate the pace of discovery of new treatments for metabolic bone disease Benefits and Advantages Early detection - long before bone damage occurs Rapid results High level of detail Safe only uses blood or urine Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Anbar's departmental webpage Dr. Anbar's research webpage

AB - Loss of bone mineral content leads to a variety of significant medical problems including osteoporosis. Development of new treatments for metabolic bone disease as well as evaluation of the efficacy of current treatments is severely hampered by the lack of a reliable tool for quickly measuring changes in bone mineral balance (BMB). Methods to sensitively measure BMB could tremendously benefit research and clinical practice in the study and treatment of bone disease. Researchers at Arizona State University have developed a novel technique that utilizes tracer-less calcium isotopes to measure net bone mineral balance. This technique analyzes changes in the natural isotope composition of calcium in blood and urine resulting from the balance of bone formation vs. resorption. Utilizing mass spectrometry, changes in bone mineral balance may be revealed with unprecedented speed and detail. Measurement of a complimentary strontium isotope biomarker provides, with equal rapidity, information on the speed of exchange of calcium between soft tissue and mineralized compartments. Ca isotope analysis provides a powerful means to monitor bone loss and therapeutic efficacy of treatments. Moreover, it may allow for new and quicker diagnoses of metabolic bone diseases in a safe and rapid manner. Potential Applications Bone mineral balance research Early detection of bone disease Assessment of effectiveness of current treatments Accelerate the pace of discovery of new treatments for metabolic bone disease Benefits and Advantages Early detection - long before bone damage occurs Rapid results High level of detail Safe only uses blood or urine Dowload Original PDF For more information about the inventor(s) and their research, please see Dr. Anbar's departmental webpage Dr. Anbar's research webpage

M3 - Patent

ER -